SECO 2025: Retina, imaging, and technological monitoring in AMD

In recent years, advancements in technology have revolutionized the field of optometry, providing new ways to diagnose, monitor, and treat retinal diseases. These innovations are not only improving patient outcomes but also making it easier for eye care professionals to provide timely interventions. Ahead of SECO, which is taking place in Atlanta, Georgia, February 26-March 2, 2025, Julie Rodman, OD, MS, FAAO, sat down to discuss the keynote session, "Expansion of eye care: What's new and what's next?" as well as her other presentations on imaging, retinal care, and the posterior segment.

Enhancing AMD care with home monitoring devices

One of the most promising advancements in eye care technology is the development of home monitoring devices. One such device, ForeseeHOME (Notal Vision), is designed for patients with intermediate dry age-related macular degeneration (AMD). This device enables patients to monitor their condition from the comfort of their own homes, with automatic alerts sent to their doctors if any significant changes are detected. By incorporating this technology, optometrists can catch disease progression earlier, enabling timely intervention and potentially preserving vision for at-risk patients.

Another innovation on the horizon is the SCANLY Home OCT (Notal Vision) device. While not yet widely available, this technology could offer patients greater convenience and allow eye care professionals to track retinal changes remotely. As these devices continue to evolve, they have the potential to redefine the way optometrists manage chronic eye diseases.

Artificial intelligence: A growing influence in optometry

Artificial intelligence (AI) is increasingly becoming a focal point in medical research, including eye care. While its use in clinical settings is still developing, AI-powered platforms are already being integrated into some home monitoring devices, such as the aforementioned ForeseeHOME system. These platforms analyze data and notify doctors of any concerning changes, allowing for faster and more efficient decision-making.

For optometrists eager to stay on the cutting edge, staying informed about AI-driven technologies is crucial. Attending educational sessions, collaborating with peers, and exploring AI applications in eye care can help practitioners integrate this technology into their practices.

The impact of OCT-A in retinal imaging

One of the most significant innovations in optometry over the past decade is optical coherence tomography angiography (OCT-A). Before OCT-A, optometrists had to refer patients for fluorescein angiography—an invasive procedure with potential side effects. With OCT-A, practitioners can now noninvasively visualize the retinal vasculature, allowing for earlier detection and monitoring of diseases such as diabetic retinopathy and AMD.

This technology has also empowered optometrists to play a more active role in managing retinal conditions, reducing the need for immediate referrals and enabling more comprehensive in-office care. OCT-A enhances both diagnostic capabilities and patient retention within optometric practices.

Advancements in AMD and diabetic retinopathy treatments

Innovative treatments for AMD and diabetic retinopathy continue to emerge, offering new hope for patients. Complement inhibitors for geographic atrophy, an advanced form of dry AMD, represent a major breakthrough in slowing disease progression. Similarly, new research into diabetic retinopathy treatments is expanding the options available for managing this condition more effectively.

Embracing the future of optometry

The field of optometry is undergoing a rapid transformation, driven by cutting-edge technologies and new treatment modalities. For optometrists and eye care professionals, staying informed about these advancements is essential to providing the highest level of care. By incorporating home monitoring devices, exploring AI applications, leveraging OCT-A imaging, and staying up to date on emerging treatments, practitioners can continue to enhance patient outcomes and redefine the future of eye care.